6-Fluoro-5-[4-[(5-Fluoro-2-Methyl-3-Oxo-4H-Quinoxalin-6-Yl)Methyl]Piperazin-1-Yl]-N-Methylpyridine-2-Carboxamide

2 trials 2 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

1 Sponsors

4 Countries

Phase I (FiH)

Phase I (FiH): 2

Indications tested

Bladder cancer 1 Ovarian cancer 1 Metastatic glioma 1 Metastases to biliary tract 1 Prostate cancer metastatic 1 Breast cancer 1 Prostate cancer 1

Sponsors using this IMP

AstraZeneca AB 2

All trials

2 total

(Title in lay language): A trial to learn how safe AZD0516 is and how well it works with and without other cancer treatments in adults with … Recruiting

2024-520026-11-00 Phase I (FiH) 3 countries AstraZeneca AB
Study of AZD9574 as monotherapy and in combination with anti-cancer agents in patients with advanced solid malignancies Recruiting

2023-504984-17-00 Phase I (FiH) 2 countries AstraZeneca AB

Showing 1–2 of 2 trials

← All drugs A–Z